Role of p38 in the priming of human neutrophils by peritoneal dialysis effluent

Clinical and Diagnostic Laboratory Immunology

Volumn 6, Issue 6, 1999, Pages 878-884

  Daniels, Ian ^a   Fletcher, John ^a   Haynes, Andrew Paul ^a  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ENZYME INHIBITOR; GENISTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PERITONEAL DIALYSIS FLUID; PHOSPHOLIPASE A2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; SYNAPTOPHYSIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; MOLECULAR DYNAMICS; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION;

EID: 0032706802     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.6.6.878-884.1999     Document Type: Article

References (38)

1. Avdi, N. J., B. W. Winston, M. Russel, S. K. Young, G. L. Johnson, and G. S. Worthen. 1996. Activation of MEKK by fMLP in human neutrophils. J. Biol. Chem. 271:33596-33606.
2. phox by p38 and ERK but not by JNK. Arch. Biochem. Biophys. 334:395-400.
3. Boyum, A. 1968. Isolation of mononuclear cells and granulocytes from human blood. Scand. J. Clin. Lab. Investig. 21(Suppl. 97):77-89.
4. Crouch, S. P. M., R. Kozlowski, K. J. Saltier, and J. Fletcher. 1993. The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity. J. Immunol. Methods 160:81-88.
5. Daniels, I., M. A. Lindsay, C. I. C. Keany, R. P. Burden, J. Fletcher, and A. P. Haynes. 1998. The role of arachidonic acid and its metabolites in the priming of human PMN NADPH oxidase by peritoneal dialysis effluent. Clin. Diagn. Lab. Immunol. 5:683-689.
6. Daniels, I., M. Lindsay, C. Porter, A. P. Haynes, J. Fletcher, and A. G. Morgan. 1993. Effect of peritoneal dialysis effluent on superoxide anion production by polymorphonuclear neutrophils. Nephron 64:382-387.
7. Daniels, I., K. S. S. Bhatia, C. J. Porter, M. A. Lindsay, A. G. Morgan, R. P. Burden, and J. Fletcher. 1996. Hydrogen peroxide generation by polymorphonuclear leukocytes exposed to peritoneal dialysis effluent. Clin. Diagn. Lab. Immunol. 3:682-688.
8. Daniels, I., S. P. M. Crouch, M. Lindsay, A. G. Morgan, R. P. Burden, and J. Fletcher. 1994. Primary and secondary granule release by polymorphonuclear leukocytes exposed to peritoneal dialysis effluent. Clin. Diagn. Lab. Immunol. 1:227-231.
9. 2. J. Clin. Investig. 93: 1583-1591.
10. 2. Biochem. J. 308:815-822.
11. Gomez-Cambronero, J., J. M. Colasanto, C. K. Huang, and R. I. Shaafi. 1993. Direct stimulation by tyrosine phosphorylation of MAP kinase activity by GMCSF in human neutrophils. Biochem. J. 291:211-217.
12. Hardy, S. J., A. Ferrante, B. S. Robinson, D. W. Johnson, and A. W. Murray. 1994. Effect of exogenous fatty acids with greater than 22 carbon atoms (very long chain fatty acids) on superoxide production by human neutrophils. J. Immunol. 153:1754-1761.
13. Jiang, Y., C. Chen, Z. Li, W. Guo, J. Gegner, S. Lin, and J. Han. 1996. Characterisation of the structure and function of a new mitogen-activated protein kinase (p38β). J. Biol. Chem. 271:17920-17926.
14. 2. Biochim. Biophys. Acta. 959:269-279.
15. Krump, E., J. S. Sanghera, S. L. Pelech, W. Furuya, and S. Grinsteib. 1997. Chemotactic peptide n-fMLP activation of p38 MAP kinase and MAPK-activated protein kinase 2 in human neutrophils. J. Biol. Chem. 272:937-944.
16. 2 is phosphorylated and activated by MAP kinase. Cell 72:269-278.
17. Lindsay, M. A., I. Daniels, and J. Fletcher. 1997. Phospholipases and the activation and priming of neutrophils by peritoneal dialysis effluent. Perit. Dial. Int. 17:471-479.
18. Lindsay, M. A., I. Daniels, and J. Fletcher. 1996. Investigation of the role of PKC and tyrosine kinases during the rapid and sustained release of superoxide from adherent human neutrophils. Biochem. Soc. Trans. 24:678.
19. Lowry, O. H., M. L. Rosenbrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275.
20. 2 in human polymorphonuclear leukocytes. Biochim. Biophys. Acta 879:149-156.
21. Matsuda, S., Y. Gotoh, and E. Nishida. 1994. Signaling pathways mediated by the mitogen-activated protein (MAP) kinase kinase/MAP kinase cascade. J. Leukoc. Biol. 56:548-553.
22. Mocsai, A., B. Banfi, A. Kapus, G. Farkas, M. Geiszt, L. Buday, A. Farago, and E. Legeti. 1997. Differential effects of tyrosine kinase inhibitors and an inhibitor of MAP kinase cascade on degranulation and superoxide production of human granulocytes. Biochem. Pharmacol. 54:781-789.
23. 2 in human neutrophils. Biochem. J. 313:503-508.
24. Nick, J. A., N. J. Avdi, P. Gerwins, G. L. Johnson, and G. S. Worthen. 1996. Activation of a p38 mitogen-activated protein kinase in human neutrophils by lipopolysaccharide. J. Immunol. 156:4867-1875.
25. Nick, J. A., N. J. Avdi, S. C. Young, C. Khall, P. Gerwins, G. L. Johnson, and G. S. Worthen. 1997. Common and distinct intracellular signalling pathways in human neutrophils utilized by platelet activating factor and fMLP. J. Clin. Investig. 99:975-986.
26. 558. Blood 79:1563-1573.
27. 2 by granulocyte-macrophage colony-stimulating factor and its role in priming superoxide production. Br. J. Haematol. 92:804-814.
28. Rossomondo, A. J., J. S. Sanghera, L. A. Marsden, M. J. Weber, S. L. Pelech, and T. W. Sturgill. 1991, Biochemical characteristics of a family of serine/ threonine protein kinases regulated by tyrosine and serine/threonine phosphorylations. J. Biol. Chem. 266:20270-20275.
29. Schnyder, B., P. C. Meunier, and B. D. Car. 1998. Inhibition of kinases impairs neutrophil activation and killing of Staphylococcus aureus. Biochem. J. 331:489-495.
30. Thompson, H. L., M. Shiroo, and J. Saklatvala. 1993. The chemotactic factor n-fMLP activates microtubule associated protein 2 (MAP) kinase and a MAP kinase kinase in polymorphonuclear leucocytes. Biochem. J. 290:483-488.
31. Torres, M., F. L. Hall, and K. O'Neil. 1993. Stimulation of human neutrophils with fMLP induces tyrosine phosphorylation and activation of two distinct mitogen-activated protein-kinases. J. Immunol. 150:1563-1578.
32. Waterman, W. H., and R. I. Shaafi. 1995. Effects of granulocyte-macrophage colony-stimulating factor and tumour necrosis factor-α on tyrosine phosphorylation and activation of mitogen-activated protein kinases in human neutrophils. Biochem. J. 307:39-45.
33. 2 in human neutrophils stimulated with TNF-α. Biochem. Biophys. Res. Commun. 209:271-278.
34. 2 are abrogated by an inhibitor of the p38 mitogen-activated protein kinase cascade in human neutrophils. Biochem. J. 319:17-20.
35. Yoshitomi, A., and M. J. Pabst. 1990. Priming of neutrophils by lipopolysaccharide for enhanced release of superoxide. J. Immunol. 145:3017-3025.
36. Young, P. R., M. M. McLaughlin, S. Kumerm, S. Kassis, M. L. Doyle, D. McNulty, T. F. Gallagher, S. Fisher, P. C. McDonnell, A. Carr, M. J. Huddleston, G. Seibel, T. G. Porter, G. P. Livi, J. L. Adams, and J. C. Lee. 1997. Pyridinyl imidazole inhibitors of p38 mitogen-activated protein kinase bind in the ATP site. J. Biol. Chem. 272:12116-12121.
37. Zu, Y. L., J. Qi, A. Gilchrist, G. A. Fernandez, D. Vazquez-Abad, D. L. Kreutzer, C. K. Huang, and R. I. Sha'afi. 1998. P38 mitogen-activated protein kinase activation is required for human neutrophil function triggered by TNF-α. J. Immunol. 160:1982-1989.
38. Zu, Y. L., Y. Ai, A. Gilchrist, M. E. Labadia, R. I. Shaafi, and C. K. Huang. 1996. Activation of MAP kinase-activated protein kinase 2 in human neutrophils after phorbol ester or fMLP peptide stimulation. Blood 87:5287-5296.